top of page
COMPANY
History
SCROLL DOWN
We continue to achieve sustained growth by building a robust pipeline powered by differentiated molecular glue technology.
2025
Dec
Selected for the Scale-Up TIPS Program
Oct
Selected for a KDDF (Korea Drug Development Fund) project for candidate drug development
Sep
Raised Pre-Series A Funding
May
Certified as an In-house R&D Center
Headquarters Relocated to Munjeong-dong
2024
Sep
Selected for the TIPS Program
July
Certified as a Venture Company
June
Raised Seed Funding
2022
May
Founded PROTIER Biotech Inc.
bottom of page